Janet Gage
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Janet Gage.
Experimental Eye Research | 1977
Michael Berman; R. Leary; Janet Gage
“Latent” collagenase† has been activated by brief trypsin treatment of crude culture media protein from both ulcerating and non-ulcerating (normal) rabbit corneas. Collagenase activity generated in this way is able to cleave re-constituted collagen in fibrils and cleaves soluble collagen into 34- and 14-length fragments in the manner of the vertebrate collagenases. Collagenase activity has been generated also by trypsin treatment of molecular sieve fractions containing protein only slightly larger in size than the manifest collagenase of approximately 40 000 mol weight. Both latent and manifest collagenase treated with trypsin elute with an apparent molecular weight of 23 000 and are capable of being bound by the serum antiprotease, α2-macroglobulin. The nature of the latent collagenase is not known. It may be a complex of collagenase with an inhibitor, or it may be a zymogen.
Experimental Eye Research | 1975
Michael Berman; James Gordon; Luis A. Garcia; Janet Gage
Previous work has demonstrated that whole rabbit or human serum and the human α2-macroglobulin (Hα2-m) inhibit corneal collagenases. In the present study, the ability of rabbit and human serum to cause rabbit corneal collagenase, mol. wt 45 000, to elute in high molecular weight fractions from sieving columns is taken as presumptive evidence for the formation of collagenase-serum protein complexes. The recovery of increased collagenase activity by thiocyanate treatment of serum effluent fractions containing the human α2-macroglobulin indicates that it is the α2-m in human serum that complexes rabbit corneal collagenase. This conclusion is supported by the demonstration that purified Hα2-m transports the rabbit corneal collagenase through a molecular sieve. Moreover, the chromatography of day one culture media from ulcerating rabbit corneas has demonstrated the presence of a significant amount of the total collagenase activity in the high molecular weight (850 000 – 1 000 000) fractions in which rabbit α-macroglobulin (Rα1-m) was also demonstrated. These observations support the hypothesis that the α-macroglobulins play an important role in the regulation of corneal collagenase activity. Crossed-gel immunoelectrophoretic methods have shown that rabbit and human corneal collagenase preparations perturb the patterns of their respective α-macroglobulins. The perturbed patterns are taken as evidence for the formation of collagenase-α-macroglobulin complexes. The application of crossed-gel methods to the tears of human ulcer patients shows the utility of such methods for examining the status of α2-m in tears.
Experimental Eye Research | 1976
Michael Berman; H. Dwight Cavanagh; Janet Gage
Abstract Dibutyryl cyclic-AMP (DBcAMP) and theophylline partially inhibit the appearance of collagenase activity when added to cultures of ulcerating rabbit corneas. Drug treatment with DBcAMP also inhibits degradation of collagen in the explanted corneas as measured by hydroxyproline in the media. The hydrolysis product of DBcAMP, 5′-adenosine monophosphate (5′ AMP) is itself very effective in suppressing collagenase activity and the degradation of explant collagen. The mechanism(s) of the drug effects is not yet known but it is possible that the drugs affect the synthesis and/or the secretion of collagenase. The results suggest that “first messengers” exist which can prevent the secretion of corneal collagenase by raising endogenous cAMP in corneal cells through stimulation of the adenyl cyclase system. Eventual successful treatment of corneal ulceration might well require pharmacologic intervention at multiple levels: the biosynthesis, secretion, activation and activity of collagenase.
Experimental Eye Research | 1977
Michael Berman; H. Dwight Cavanagh; Janet Gage
Abstract Alkali-burned rabbit corneas were treated topically with 5′ adenosine monophosphate (5′ AMP) in an attempt to prevent corneal ulceration. Drug treatment did not reduce the frequency or the severity of ulceration compared to treatment with an osmotically-matched saline control. Ulcerating corneas were cultured subsequently in control medium or in medium containing 5′ AMP. Corneas that had received saline in vivo produced high levels of collagenase activity and showed extensive explant degradation when cultured in control medium. When cultured in the presence of 5′ AMP, however, such corneas produced barely-detectable levels of collagenase, and explants were not apparently degraded. Corneas that had received 5′ AMP in vivo also produced high levels of collagenase activity and showed extensive explant degradation when cultured in control medium. When cultured in medium containing 5′ AMP, however, such corneas showed minimal degradation as evidenced by their appearance and by the very low hydroxyproline levels in the media. Significantly, media harvested from such cultures contained high levels of collagenase activity.
Investigative Ophthalmology & Visual Science | 1979
Kenneth R. Kenyon; Michael R. Berman; Jeannette Rose; Janet Gage
Investigative Ophthalmology & Visual Science | 1980
Michael Berman; Richard Leary; Janet Gage
Archives of Ophthalmology | 1978
Peter C. Donshik; Michael Berman; Claes H. Dohlman; Janet Gage; Jeannette Rose
Investigative Ophthalmology & Visual Science | 1982
Michael R. Berman; S Winthrop; D Ausprunk; J Rose; Robert Langer; Janet Gage
Investigative Ophthalmology & Visual Science | 1980
Conn H; Michael R. Berman; Kenneth R. Kenyon; Robert Langer; Janet Gage
Investigative Ophthalmology & Visual Science | 1979
Michael Berman; R Leary; Janet Gage